Literature DB >> 11013366

Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva.

S H Zhang1, A K Sood, J I Sorosky, B Anderson, R E Buller.   

Abstract

BACKGROUND: Traditional inguinal lymphadenectomy includes the removal of a portion of the saphenous vein. The authors hypothesized that preserving the saphenous vein would decrease morbidity without affecting treatment outcome.
METHODS: A retrospective review of 83 patients with carcinoma of the vulva who underwent inguinal lymphadenectomy between 1990-1998 was performed. Postoperative short term and long term complications were evaluated.
RESULTS: A total of 139 inguinal dissections were performed in 83 patients. The saphenous vein was preserved in 62 patients and ligated in 77 patients. The clinical characteristics of the patients, the operating time, and the estimated blood loss were not significantly different between the two groups. The incidence rate of short term complications including fever, seroma, phlebitis, lymphocyst, and deep venous thrombosis also was similar. Cellulitis occurred in 39% of the patients who underwent vein ligation compared with 18% of the patients who underwent a vein-sparing procedure (P = 0.006). Short term (< 6 months) lower extremity lymphedema occurred in 70% of the vein-ligated group compared with 32% of the vein-spared group (P < 0. 001). Chronic edema (>/= 2 years) was present in only 3% of the patients who underwent saphenous vein preservation compared with 32% of those who underwent vein ligation (P = 0.003). Chronic lymphedema in the vein-spared group was observed in only one patient who received postoperative radiation. Overall, individuals with preservation of the saphenous vein were less likely to develop complications (56% vs. 23%; P < 0.001). There was no difference in the rate of incidence of recurrent disease between the two groups.
CONCLUSIONS: Preservation of the saphenous vein during inguinal lymphadenectomy reduces both the short term and long term postoperative complications without affecting treatment outcome. The saphenous vein should be preserved routinely in patients undergoing inguinal lymphadenectomy.

Entities:  

Mesh:

Year:  2000        PMID: 11013366

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM.

Authors:  F Egberts; C Hartje; C Schafmayer; K C Kaehler; W von Schönfels; A Hauschild; T Becker; J H Egberts
Journal:  Ann R Coll Surg Engl       Date:  2011-10       Impact factor: 1.891

2.  Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.

Authors:  Sharon B Chang; Robert L Askew; Yan Xing; Storm Weaver; Jeffrey E Gershenwald; Jeffrey E Lee; Richard Royal; Anthony Lucci; Merrick I Ross; Janice N Cormier
Journal:  Ann Surg Oncol       Date:  2010-03-25       Impact factor: 5.344

Review 3.  Surgical management of metastatic inguinal lymphadenopathy.

Authors:  Marc C Swan; Dominic Furniss; Oliver C S Cassell
Journal:  BMJ       Date:  2004-11-27

4.  Surgical management of metastatic inguinal lymphadenopathy: the term deep inguinal nodes should be abandoned.

Authors:  Simon C Gibson; Stephen Kettlewell; Dominique S Byrne; Alan J McKay
Journal:  BMJ       Date:  2005-03-05

Review 5.  Management of lymph nodes in the treatment of vulvar cancer.

Authors:  Toshiaki Saito; Keiji Kato
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

6.  Robotic inguinal lymph node dissection for melanoma: a novel approach to a complicated problem.

Authors:  G Alan Hyde; Nathan L Jung; Alvaro A Valle; Syamal D Bhattacharya; Christopher E Keel
Journal:  J Robot Surg       Date:  2018-01-06

7.  Saphenous vein sparing during laparoscopic bilateral inguinal lymphadenectomy for penile carcinoma patients.

Authors:  Yu Cui; Hequn Chen; Longfei Liu; Zhi Chen; Jinbo Chen; Lin Qi; Xiongbing Zu
Journal:  Int Urol Nephrol       Date:  2015-12-10       Impact factor: 2.370

8.  Use of neutral plasma coagulation in groin node dissection for vulvar malignancy: a novel technique.

Authors:  Thumuluru Kavitha Madhuri; Anil Tailor; Simon Butler-Manuel
Journal:  Cancer Manag Res       Date:  2011-07-06       Impact factor: 3.989

9.  Selective inguinal lymphadenectomy in the treatment of invasive squamous cell carcinoma of the vulva.

Authors:  Christopher P Desimone; Jeffrey Elder; John R van Nagell
Journal:  Int J Surg Oncol       Date:  2011-06-09

10.  Risk factors for short- and long-term complications after groin surgery in vulvar cancer.

Authors:  F Hinten; L C G van den Einden; J C M Hendriks; A G J van der Zee; J Bulten; L F A G Massuger; H P van de Nieuwenhof; J A de Hullu
Journal:  Br J Cancer       Date:  2011-10-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.